相似文献
1
Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK.
Emerg Infect Dis. 2007 May;13(5):761-3. doi: 10.3201/eid1305.061124.
2
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284.
3
Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
Am J Infect Control. 2020 Oct;48(10):1152-1157. doi: 10.1016/j.ajic.2020.01.011. Epub 2020 Feb 29.
4
Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.
Antimicrob Agents Chemother. 2014 Jul;58(7):4214-8. doi: 10.1128/AAC.02775-13. Epub 2014 Apr 21.
5
Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada.
Antimicrob Agents Chemother. 2012 Feb;56(2):639-46. doi: 10.1128/AAC.05411-11. Epub 2011 Nov 21.
6
Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.
J Clin Microbiol. 2013 May;51(5):1465-73. doi: 10.1128/JCM.03352-12. Epub 2013 Feb 27.
7
Community-acquired Clostridium difficile infection in Serbian pediatric population.
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1061-1069. doi: 10.1007/s10096-018-3218-6. Epub 2018 Mar 1.
8
Risk Factors for Community-associated Clostridium difficile-associated Diarrhea in Children.
Pediatr Infect Dis J. 2015 Sep;34(9):919-23. doi: 10.1097/INF.0000000000000767.
9
Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
Antimicrob Resist Infect Control. 2020 Sep 25;9(1):158. doi: 10.1186/s13756-020-00815-5.
10
Antimicrobial resistance in ribotype 017.
Expert Rev Anti Infect Ther. 2020 Jan;18(1):17-25. doi: 10.1080/14787210.2020.1701436. Epub 2019 Dec 6.
引用本文的文献
1
Systemic Absorption of Oral and Rectal Vancomycin in a Critically Ill Patient: A Case Report.
Cureus. 2024 Dec 19;16(12):e76008. doi: 10.7759/cureus.76008. eCollection 2024 Dec.
2
Evaluation of anti-infective-related -associated colitis using the Japanese Adverse Drug Event Report database.
Int J Med Sci. 2020 Mar 26;17(7):921-930. doi: 10.7150/ijms.43789. eCollection 2020.
3
Cationic Anthraquinone Analogs as Selective Antimicrobials.
Microbiol Insights. 2019 May 20;12:1178636119847809. doi: 10.1177/1178636119847809. eCollection 2019.
4
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.
Infect Dis Ther. 2016 Sep;5(3):231-51. doi: 10.1007/s40121-016-0117-y. Epub 2016 Jul 1.
5
Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.
Antibiotics (Basel). 2015 Jun 19;4(2):216-29. doi: 10.3390/antibiotics4020216.
6
Excess Mortality Attributable to Clostridium difficile and Risk Factors for Infection in an Historic Cohort of Hospitalised Patients Followed Up in the United Kingdom Death Register.
PLoS One. 2016 Mar 21;11(3):e0149983. doi: 10.1371/journal.pone.0149983. eCollection 2016.
7
The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study.
PLoS One. 2014 Aug 26;9(8):e105454. doi: 10.1371/journal.pone.0105454. eCollection 2014.
8
Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole.
PLoS One. 2014 Jan 6;9(1):e82622. doi: 10.1371/journal.pone.0082622. eCollection 2014.
9
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.
Antimicrob Agents Chemother. 2013 May;57(5):2326-32. doi: 10.1128/AAC.02176-12. Epub 2013 Mar 11.
10
Community-associated Clostridium difficile infections, Monroe County, New York, USA.
Emerg Infect Dis. 2012 Mar;18(3):392-400. doi: 10.3201/eid1803.102023.
本文引用的文献
1
ICD-9 codes and surveillance for Clostridium difficile-associated disease.
Emerg Infect Dis. 2006 Oct;12(10):1576-9. doi: 10.3201/eid1210.060016.
2
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284.
3
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
Antimicrob Agents Chemother. 2006 Sep;50(9):3216-9. doi: 10.1128/AAC.00592-06.
4
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.
Emerg Infect Dis. 2006 Mar;12(3):409-15. doi: 10.3201/eid1205.051064.
5
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
JAMA. 2005 Dec 21;294(23):2989-95. doi: 10.1001/jama.294.23.2989.
6
An epidemic, toxin gene-variant strain of Clostridium difficile.
N Engl J Med. 2005 Dec 8;353(23):2433-41. doi: 10.1056/NEJMoa051590. Epub 2005 Dec 1.
7
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.
N Engl J Med. 2005 Dec 8;353(23):2442-9. doi: 10.1056/NEJMoa051639. Epub 2005 Dec 1.
8
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
Clin Infect Dis. 2005 Nov 1;41(9):1254-60. doi: 10.1086/496986. Epub 2005 Sep 20.
9
Fluoroquinolone use and Clostridium difficile-associated diarrhea.
Emerg Infect Dis. 2003 Jun;9(6):730-3. doi: 10.3201/eid0906.020385.
10
Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut.
J Antimicrob Chemother. 2003 Jul;52(1):96-102. doi: 10.1093/jac/dkg267. Epub 2003 May 29.
Zotero 插件